Skip to content

How common is dry eye disease after phacoemulsification cataract surgery

Incidence of dry eye in a patient undergoing phacoemulsification cataract surgery - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/12/099192
Enrollment
94
Registered
2025-12-16
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H259- Unspecified age-related cataract

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Sponsors

Dr ABU SAQUIB AFZAL HAQUE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients 40 years of age and older are undergoing phacoemulsification cataract surgery with intraocular lens implantation without any problems 2)willingness to cooperate with follow-up visits and give informed consent. the capacity to comprehend and reply to surveys about dry eye symptoms

Exclusion criteria

Exclusion criteria: 1. Patient having DED excluded in order to distinguish DED caused by Phacoemulsification cataract surgery from preexisting condition. 2. History of conditions affecting the surface of the eyes, such as allergic conjunctivitis, blepharitis, or pterygium. 3. Trauma to the operating eye or prior eye operations. 4. Systemic diseases such Sjogren syndrome, rheumatoid arthritis, or uncontrolled diabetes mellitus that are known to impact tear production. 5. Patients those who wear contact lenses. 6. Use of systemic drugs such as Amiodarone, Busulfan, Steroid 7. A cataract that develops due to factors other than aging, such as trauma, uveitis, or medication side effects 8. Glaucoma and patient having pre-existing ocular diseases such as conjunctivitis, keratitis 9. Radiation and chemical burns. 10. Patient with previous ocular surgeries as SMILE, LASIK, KERATOPLASTY 11. Use of topical eye drugs particularly antihistamine within three months following surgery, except for common postoperative drops like antibiotics and steroids

Design outcomes

Primary

MeasureTime frame
To compare the health of the ocular surface and the stability of the tear film before and after phacoemulsification surgery using metrics such as Schirmers test, TBUT, corneal staining, within the time of 3 monthsTimepoint: Baseline, Post operative 1st week, 4th weeks, 12th weeks

Secondary

MeasureTime frame
To assess the association of demographic elements for dry eye diseaseTimepoint: Baseline, Post operative 1st weeks, 4th weeks, 12th weeks

Countries

India

Contacts

Public ContactDr Abu Saquib Afzal Haque

NETAJI SUBHAS MEDICAL COLLEGE AND HOSPITAL

drsaq@proton.me8877884360

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026